Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cytomx Therapeutics Inc | 3.070% | -1.300% | -16.431% | -21.838% | -23.854% | -75.291% | -86.592% |
| Viking Therapeutics Inc | 2.370% | 0.485% | 10.683% | 363.604% | 231.827% | 946.159% | 815.575% |
| Novavax Inc. | 9.340% | 4.538% | -1.008% | 46.276% | 150.750% | -94.343% | 99.857% |
| Compugen Ltd. | -1.700% | - | - | - | - | - | - |
| ImmunityBio Inc. | 3.110% | -5.892% | -26.680% | 136.954% | -24.195% | -62.949% | 225.569% |
| Adaptimmune Therapeutics PLC ADR | -1.750% | 6.481% | -5.738% | 51.316% | 84.000% | -73.624% | -21.233% |
| Sangamo Therapeutics Inc. | 5.100% | -0.131% | 15.854% | -12.159% | 32.655% | -90.885% | -92.310% |
| Insmed Inc. | - | -3.521% | 0.735% | 242.500% | 139.510% | 195.259% | 358.071% |
| Puma Biotechnology Inc. | 3.270% | -2.118% | -37.060% | -33.988% | -43.201% | -65.634% | -76.653% |